Gunze launches UV Therapy Device for Dermatology “CAREVEAM” in Japan, through its subsidiary Gunze Medical
News
Gunze launches UV Therapy Device for Dermatology “CAREVEAM” in Japan, through its subsidiary Gunze Medical
Osaka-Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medical Limited (Headquarters: Osaka, Japan; President: Shojiro Matsuda "Gunze Medical") will start selling “CAREVEAM”, an ultraviolet light therapy device for the treatment of skin diseases to medical institutions nationwide on July 1, 2025.
This product is a table-mounted 308 nm excimer UV‑B phototherapy lamp developed by LAMEDITECH in Korea, and Gunze Medical has concluded an exclusive sales agreement with LAMEDITECH in Japan.
CAREVEAM, an ultraviolet light treatment device for dermatology
■About CAREVEAM, an ultraviolet light treatment device for dermatology
CAREVEAM is an ultraviolet light treatment device for dermatological conditions such as psoriasis and vitiligo. It utilizes a targeted excimer lamp with a wavelength of 308nm. The product is designed to provide peace of mind for both the patient and the practitioner by adhering to the concept of "providing peace of mind for first-time UV therapy." The irradiance can be adjusted with precision according to the symptoms and skin conditions of the individual patient, allowing for a flexible response to their specific treatment needs. Additionally, the lightweight handpiece and compact design reduce the burden on the practitioner's wrist, making it comfortable to use even over long periods of time. The following are major indications: psoriasis, vitiligo, atopic dermatitis, alopecia areata, mycosis fungoides, and eczema.
In Japan, the product has obtained manufacturing and marketing approval and insurance coverage. The product obtained CE marking in 2020 and has already been sold in Taiwan, Egypt, the UAE, and South Korea. The product will be planned to expand sales to Europe, Germany, Israel, and the United States.
■About Gunze Medical Limited
Gunze Medical Limited was founded in 1986 in Osaka, Japan. It is a wholly owned subsidiary of Gunze Limited. Its product lines are sales of medical devices (plastic and reconstructive surgery, neurosurgery, oral surgery, cardiovascular surgery, cosmetic surgery, pediatric surgery, dermatology, etc.) and consulting for opening medical facilities. Gunze Medical delivers a better future for patients by providing innovative "Biomaterials x Devices".
■About LAMEDITECH Co., Ltd
LAMEDITECH Co., Ltd was founded in 2012 in Seoul, South Korea. They develop and manufacture laser- and UV-based medical devices for both human and veterinary health.
This news release is intended to provide information about Gunze's corporate activities and an overview of its initiatives to a wide range of stakeholders, including members of the press, shareholders, investors, and other interested parties, in a fair and timely manner.
The information contained in this document regarding our products and services is not intended to solicit customers or provide medical advice.
Contacts
Press
Gunze Limited Corporate Communication Department TEL： 81-6-6348-1314 (Shinji Nonaka, Saki Okazaki)
Information posted here (product information, market launch date, contact, URL, etc.) is as of release date. Posted information is subject to change without notice.
